From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Inflammation from ADT may cause fatigue in prostate cancer patients
Prostate cancer is one of the most common cancers among men in the US. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens in the body. Lowering androgen levels can make prostate cancer cells grow more slowly or shrink tumors over time. However, patients receiving ADT often experience higher levels of fatigue, depression and cognitive impairment.
New cell therapy can boost immunotherapy against breast cancer
Boosting immune system T cells to effectively attack solid tumors, such as breast cancers, can be done by adding a small molecule to a treatment procedure called chimeric antigen receptor-T (CAR-T) cell therapy, according to a study by researchers at the UNC Lineberger Comprehensive Cancer Center.
Processed foods make us fatter and are linked to a higher risk of cancer
It's no secret that processed foods are bad for us. A recent study from Italian researchers found that eating more processed food was linked to an increasingly higher risk of dying from heart disease and stroke.
Feeling constantly bloated could be early sign of ovarian cancer
Ovarian cancer is the sixth most common cancer in the UK. Knowing the early warning signs is key for earlier treatment and if having a constant feeling of being bloated it could indicate your risk.
‘Alternating bouts of constipation and diarrhea’ could be sign of bowel cancer
Bowel cancer symptoms can be subtle and easily-missed, but as there's currently no cure it's important to be familiar with what to look out for. One of the most common signs is a change of bowel habits — "alternating bouts of constipation and diarrhea".
Could telomere shortening protect against cancer?
Researchers at Rockefeller University studied the TIN2 protein associated with telomere length. They found that telomere shortening — a sign of cellular aging — might help protect against cancer.
Rectal cancer patients who 'watch and wait' may only need few years of stringent follow-up
A global workforce of scientists, together with docs from the Champalimaud Scientific Center, in Lisbon, Portugal, has simply revealed leads to the distinguished journal The Lancet Oncology that counsel that almost all of rectal most cancers sufferers might give you the option, within the not so distant future, to interchange aggressive colorectal surgical procedure with a course of radiochemotherapy and few years of shut surveillance.
Researchers fear cancer advances delay due to pandemic in UK
Advances in cancer research could be delayed by nearly 18 months due to the coronavirus pandemic, scientists fear.
Do you experience 'dysphagia’ when eating?  It could signal lung cancer
Lung cancer is a serious form of cancer whereby abnormal cells grow uncontrollably in the organs responsible for taking in oxygen.
Lifestyle changes can reduce incidence of lung cancer
Lung Cancer Awareness Month is celebrated in November with the aim of achieving better results for patients by raising the noise level of awareness about lung cancer and its harms.
Understanding the link between genes and lung cancer
The projected incidence of patients with cancer in India among males is 679,421 (94.1 per 100,000) and among females 712,758 (103.6 per 100,000) for the year 2020.
Biologists seeking to fight liver cancer from its environment
The second deadliest cancer in the world is liver cancer. It is particularly fatal when it affects the bile ducts. It has been studied extensively, with a focus on malignant cells, and there is virtually no effective cure.
Existing antidepressant helps to inhibit growth of cancer cells in lab animals
New research has shown that the antidepressant sertraline helps to inhibit the growth of cancer cells. The substance acts on a metabolic addiction that allows different types of cancer to grow, reported.
New cancer drugs saved over 1.2 million people in the US over 16 years, new study shows
More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between the year 2000 and 2016, thanks to ever improving treatment options — a large new national study shows.
Immunotherapy may work better in stomach cancer when combined with chemo
Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of disease and in combination with standard chemotherapy, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggested.

Page Generated in 1/8645 sec